Biosimilars And Follow-On Biologics: World Market 2013-2023VisiongainApril 30, 2013 235 Pages - SKU: VSG5058493 |
|
Global Markets for Orphan Drugs – Focus on Biologics
6/1/2013 | published by: BCC Research
This report provides:
An overview of orphan drug criteria, the history of the Orphan Drug Act and its influence and advantages inherent in orphan drug designation and future growth trends; this report focuses on
|
read more...
|
$4,400.00
|
|
Global Markets for Orphan Drugs – Focus on Non-Biologics
6/1/2013 | published by: BCC Research
This report provides:
An overview of orphan drug criteria, the history of the Orphan Drug Act and its influence and advantages inherent in orphan drug designation and future growth trends; this report focuses on
|
read more...
|
$4,400.00
|
|
Antibody Drug Conjugates Market, 2012-2023
5/31/2013 | published by: Roots Analysis Pvt. Ltd.
Antibody Drug Conjugates (ADC) are a new class of biologic therapeutics. These are complex molecules comprising of an antibody linked to few cytotoxin molecules through linker technology. This class of biologics is attracting the attention
|
read more...
|
$1,699.00
|
|
China Pharmaceutical Guidebook: (2013 Edition) Latest Chinese Regulations for Imported Drug Registration Material and Clinical Trial Requirements of Application and Approval for Imported Drug Registration: A Guidebook of Registration Application for Impo
6/1/2013 | published by: Access China Management Consulting Ltd.
China possesses a fourth population in the world and has one of the largest drug markets round the world. By 2012, sales on the Chinese drug market have reached RMB 926.1billion (about US$147 billion) reported
|
read more...
|
$1,495.00
|
|
PharmaSphere: Global Biosimilars Strategy - Regulatory Landscape, Key Drivers, Markets and Trends in 2013
5/27/2013 | published by: GlobalData
PharmaSphere: Global Biosimilars Strategy - Regulatory Landscape, Key Drivers, Markets and Trends in 2013 Summary GlobalData’s PharmaSphere: Global Biosimilars Strategy - Regulatory Landscape, Key Drivers, Markets and Trends in 2013, provides strategic analysis of the global biosimilars
|
read more...
|
$2,995.00
|
|
Pharmaceutical Market India: A Comprehensive Industry Analysis
5/20/2013 | published by: Kelly Scientific Publications
Pharmaceutical Market India: A Comprehensive Industry Analysis provides you with a detailed investigation of the market size, segmentation, key players, SWOT analysis, influential Government policies, and business and economic environments. The report, Pharmaceutical Market India:
|
read more...
|
$2,620.00
|
|
BioPharmaceutical Industry in China - An In Depth Analysis of Multinational and Chinese Biopharma Companies, Industry Trends, Environment, Regulation, Market Drivers, Restraints, Opportunities & Challenges
5/16/2013 | published by: Kelly Scientific Publications
BioPharmaceutical Industry in China provides you with a detailed investigation of the market size, segmentation, key players, SWOT analysis, influential Government policies, and business and economic environments. The report, BioPharmaceutical Industry in China - An
|
read more...
|
$2,620.00
|
|
Post-Patent Generic and Biosimilar Defense Strategies
4/1/2013 | published by: Cutting Edge Information
Post-Patent Generic and Biosimilar Defense Strategies
Create Robust Counter-Generics Strategies to Maximize Market Share As Patents Expire
Fresh off of 2012’s patent cliff, the life sciences industry is bracing for a second
|
read more...
|
$7,695.00
|
|
PharmaSphere: Early-Stage Technology Transfer Collaborations - Enabling Platform Technologies & Deal Synergies between Academia and the Pharmaceutical Industry
4/30/2013 | published by: GlobalData
PharmaSphere: Early-Stage Technology Transfer Collaborations - Enabling Platform Technologies & Deal Synergies between Academia and the Pharmaceutical Industry Summary PharmaSphere: Early-Stage Technology Transfer Collaborations - Enabling Platform Technologies & Deal Synergies between Academia and the Pharmaceutical Industry
|
read more...
|
$2,995.00
|
|
Biologicals in Oncology Drug Pipeline Update 2013
4/22/2013 | published by: BioSeeker Group AB
Biologicals in Oncology Drug Pipeline Update 2013
This drug pipeline update covers a wide array of biological drugs, such as: antibodies,proteins, peptides, DNA, RNA and cellular therapies.
read more... |
$9,371.25
|
Research assistance
We can help you find what you need. Call us or write us: Need help in your search?
US: 800.298.5699
Int'l: +1.240.747.3093
Related Markets
Biopharmaceuticals Reports
- Global Markets for Orphan Drugs – Focus on Biologics
- Biologic Drug R&D in China - Current State and Future Development
- Monoclonal Antibodies Market in Rheumatoid Arthritis to 2018 - Market Characterized by Large and Diversified Pipeline and Low Threat of Biosimilar Sales Erosion
- Biologic Therapeutic Drugs: Technologies and Global Markets
- Biologic Imaging Reagents: Technologies and Global Markets